4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001170
EVP, GM Cell Therapy sold 24,890 shares at $4.55 ($113,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Groot Eleanor EVP, GM Cell Therapy | 2020-01-02 | Sale | −24,890 | $4.55 | $113,250 | 174,333 | D |
| Open-market sales · 24,890 sh · avg $4.55 · $113,250 | |||||||
Loading xslF345X03/doc4.xml…